We are live on ! Find out more
PE

Point72 Europe Portfolio holdings

AUM $2.04B
1-Year Est. Return 25.99%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+25.99%
3 Year Est. Return
+95.43%
5 Year Est. Return
+195.42%
10 Year Est. Return
AUM
$1.57B
AUM Growth
+$356M
Cap. Flow
+$283M
Cap. Flow %
18.05%
Top 10 Hldgs %
43.95%
Holding
195
New
66
Increased
30
Reduced
22
Closed
77

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$56.1M
2
CNQ icon
Canadian Natural Resources
CNQ
+$27.6M
3
ADI icon
Analog Devices
ADI
+$25.6M
4
TSM icon
TSMC
TSM
+$19M
5
VMC icon
Vulcan Materials
VMC
+$18.1M

Sector Composition

Rank Sector Weight
1 Financials 20.09%
2 Technology 14.88%
3 Energy 13.18%
4 Materials 5.4%
5 Communication Services 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTGX icon
101
Protagonist Therapeutics
PTGX
$8.92B
$2.04M 0.13%
+45,317
New +$1.83M
HOOD icon
102
Robinhood
HOOD
$77.7B
$2.02M 0.13%
86,183
-74,917
-47% -$1.58M
GPCR icon
103
Structure Therapeutics
GPCR
$3.52B
$1.97M 0.13%
44,833
+27,378
+157% +$1.06M
XLE icon
104
State Street Energy Select Sector SPDR ETF
XLE
$39.2B
$1.96M 0.12%
+44,600
New +$1.99M
SEDG icon
105
SolarEdge
SEDG
$2.54B
$1.83M 0.12%
+79,966
New +$1.94M
TSLA icon
106
Tesla
TSLA
$1.22T
$1.75M 0.11%
+6,682
New +$1.52M
TECK icon
107
Teck Resources
TECK
$30.7B
$1.5M 0.1%
28,700
-2,900
-9% -$138K
NEM icon
108
Newmont
NEM
$101B
$1.5M 0.1%
+28,000
New +$1.39M
THD icon
109
iShares MSCI Thailand ETF
THD
$364M
$1.49M 0.1%
+21,572
New +$1.29M
SHLS icon
110
Shoals Technologies Group
SHLS
$1.49B
$1.46M 0.09%
+260,416
New +$1.56M
ITCI
111
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.42M 0.09%
19,385
-12,915
-40% -$971K
LI icon
112
Li Auto
LI
$14B
$1.39M 0.09%
+54,190
New +$1.1M
BKR icon
113
Baker Hughes
BKR
$59.5B
$1.03M 0.07%
28,600
-242,336
-89% -$8.52M
ANNX icon
114
Annexon
ANNX
$863M
$947K 0.06%
159,953
-74,639
-32% -$442K
SRPT icon
115
Sarepta Therapeutics
SRPT
$1.64B
$872K 0.06%
+6,983
New +$965K
MPC icon
116
Marathon Petroleum
MPC
$91.7B
$782K 0.05%
+4,800
New +$811K
CTSH icon
117
Cognizant
CTSH
$24.3B
$679K 0.04%
+8,793
New +$655K
GEV icon
118
GE Vernova
GEV
$262B
$561K 0.04%
+2,200
New +$422K
AAPL icon
119
Apple
AAPL
$4.9T
-68,600
Closed -$14.4M
ACAD icon
120
Acadia Pharmaceuticals
ACAD
$4.55B
-50,600
Closed -$822K
AON icon
121
Aon
AON
$78.3B
-16,700
Closed -$4.9M
ASH icon
122
Ashland
ASH
$3.33B
-46,970
Closed -$4.44M
ASML icon
123
ASML
ASML
$634B
-5,300
Closed -$5.42M
AZN icon
124
AstraZeneca
AZN
$266B
-5,498
Closed -$857K
BCRX icon
125
BioCryst Pharmaceuticals
BCRX
$2.35B
-267,649
Closed -$1.65M

Similar funds

Point72 Europe's Q3 2024 Portfolio in Review

As of Q3 2024, Point72 Europe held 195 positions worth $1.57B, up 29% from $1.21B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Point72 Europe deployed $283M of net new capital in Q3 2024, opening 66 new positions and adding to 30 existing holdings. Its largest new stake was Amazon: 307,300 shares worth $57.3M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 26% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was International Flavors & Fragrances, an estimated $48M trimmed.

  • Point72 Europe's largest Q3 2024 buy was Amazon: 307,300 shares worth $57.3M.
  • Point72 Europe added most to Canadian Natural Resources in Q3 2024, an estimated $27.6M increase.
  • Point72 Europe's biggest Q3 2024 reduction was International Flavors & Fragrances, cutting an estimated $48M.
  • Point72 Europe fully exited Coca-Cola Europacific Partners in Q3 2024, selling an estimated $26.3M.
  • Point72 Europe's ten largest holdings make up 44% of its $1.57B portfolio in Q3 2024.
  • Point72 Europe opened 66 new positions and closed 77 in Q3 2024.
  • Point72 Europe's portfolio value rose 29% quarter-over-quarter to $1.57B.

Based on Point72 Europe's 13F filing for Q3 2024, filed 14 Nov 2024.